Literature DB >> 1350713

Distinct responses of interleukin-6 and other laboratory parameters to treatment in a patient with polyarteritis nodosa--a case report.

H Nakahama1, M Okada, M Miyazaki, N Imai, T Yokokawa, S Kubori.   

Abstract

The authors describe a patient in whom the serum levels of interleukin-6 (IL-6) and other laboratory parameters were monitored. The IL-6 and C-reactive protein (CRP) levels, which were extremely high before treatment, declined rapidly with administration of prednisolone. Rheumatoid factor, IgG, and platelets count declined more gradually. Thus, determination of the serum IL-6 level might be useful in diagnosing and monitoring polyarteritis nodosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350713     DOI: 10.1177/000331979204300610

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

Review 1.  Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.

Authors:  Martin Krusche; Nikolas Ruffer; Ina Kötter
Journal:  Rheumatol Int       Date:  2018-11-21       Impact factor: 2.631

2.  Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.

Authors:  Atsushi Ogata; Toshio Tanaka
Journal:  Int J Rheumatol       Date:  2012-01-18

Review 3.  A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report.

Authors:  Margaux Boistault; Mireia Lopez Corbeto; Ariadna Carsi Durall; Florence A Aeschlimann; Pierre Quartier; Laura Berbel Arcobé
Journal:  Pediatr Rheumatol Online J       Date:  2021-12-03       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.